Humoral immunity in the pathogenesis of systemic lupus erythematosus (SLE) has been well documented, but the role of cell-mediated immunity has yet to be thoroughly investigated. Although it is still a matter for debate, several workers (Bitter et al., 1971; Federlin and Helmke, 1972; Horwitz, 1972; Messner et al., 1973; Williams et al., 1973) have found depressed cellular immunity in active SLE. Goldman et al. (1972), studying patients with lupus nephritis, reported a stimulatory effect by native DNA in lymphocytes cultured in vitro, and Abe et al. (1973) observed the macrophage migration inhibition factor to DNA in vitro in their study of patients with SLE and the nephrotic syndrome.
Humoral immunity in the pathogenesis of systemic lupus erythematosus (SLE) has been well documented, but the role of cell-mediated immunity has yet to be thoroughly investigated. Although it is still a matter for debate, several workers (Bitter et al., 1971; Federlin and Helmke, 1972; Horwitz, 1972; Messner et al., 1973; Williams et al., 1973) have found depressed cellular immunity in active SLE. Goldman et al. (1972) , studying patients with lupus nephritis, reported a stimulatory effect by native DNA in lymphocytes cultured in vitro, and Abe et al. (1973) observed the macrophage migration inhibition factor to DNA in vitro in their study of patients with SLE and the nephrotic syndrome.
To further evaluate the possible role of delayed hypersensitivity to DNA in the pathogenesis of SLE nephritis, leucocyte migration inhibition tests were performed on our patients using calf thymus DNA as antigen. The results were analysed together with the immunohistological study of kidney biopsy specimens obtained simultaneously.
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The MIT was performed according to the method of S0borg and Bendixen (1967) isopentane-dry ice mixture (Lange et al., 1966) . 3 ,um thick sections were sliced on a -20°C cryostat, air dried, stained with FITC-labelled sera (Sober et al., 1956; Riggs et al., 1960) for 30 minutes in a moist chamber, and washed in 0-01 M phosphatebuffered saline pH 7-1. They were examined under a Leitz ultraviolet microscope with a 200 W Osram B high tension mercury vapour bulb and photographed with a Leitz Orthomat camera using Anscochrome 200 outdoor film.
Specimens for electron microscopy were fixed in 1 % osmium tetroxide, dehydrated in graded ethanol, and embedded in epon. Ultrathin sections were prepared on a Reichert II microtome. Sections were stained with uranyl acetate and lead citrate, then examined under a Hitachi HU-1 lA electron microscope.
Results significantly lower than that (87 % ± 5 * 9) of subjects with negative skin tests (P<0 001). The mean + 1 SD (51 % ± 10 7) for the tuberculous cases was significantly different from that of the 7 SLE patients (85% ± 26 7) and 9 normal subjects (93% i 16-5) (P<0-02 and P<0-001, respectively).
The Fig. 2 ). In the 35 controls, comprised of 19 normal subjects and 16 patients with other diseases (Table 2 , Fig. 2 ), no migration inhibition was observed except in 2 normal subjects (Cases 28, 40, Table 2 ) who showed inhibition with MII titres of 74% and 60%, respectively. The mean of the MII titre in the SLE subjects was significantly PRELIMINARY STUDIES In order to verify that MIT can be a good parameter of cellular immunity, a skin test for tuberculin PPD was simultaneously performed on 13 subjects (Fig.  1) . The mean ± 1 SD of the MII (53 % ± 12-1) for the subjects with positive skin tests was found to be patients with SLE and in control subjects.
*Each subject, either patient or control, was represented by the minimal Mll titre when MIT was done two or more times.
lower than that in the control subjects as a whole (96% ± 14 1) (P<0001). The difference in mean values between the SLE patients (71% ± 19-7) and the normal controls (92% ± 15 5) or that between SLE patients and patients with other diseases (99 % + 11 * 5) was also significant (P<0'001 in both cases; Fig. 2, Tables 1, 2 ), while the difference in mean values between normals and patients with other diseases was nonsignificant (P<0 1; Fig. 2 , Table 2 ). Of the 2 normal subjects whose MIT showed inhibition, the one with the borderline test (Case 28, 74%, Tables 1 and 2 . Although all the tests were essentially negative with the mean MII being 92% ± 7 4 for SLE, 108% ± 17 9 for normals, and 92% ± 12 4 for patients with other diseases, respectively, the difference in means between SLE and normal was significant (P<0-05). The results of the MIT with ENA in 5 SLE patients and 3 normal controls were all negative (Tables 1, 2) . Discussion Since S0borg and Bendixen (1967) first established the MIT as the simplified modification of the Proliferative -group.bmj.com on April 20, 2017 -Published by http://ard.bmj.com/ Downloaded from macrophage migration inhibition test, this assay system has been successfully used by many using particulate antigens (S0borg, 1967) . When the soluble antigens were in use their validity was doubted (Lockshin, 1969; Kaltreider et al., 1969) . Kaltreider et al. (1969) tried to find the correlation between the MIT and the results of skin tests using tuberculin PPD as the antigen. Later, Rosenberg and David (1970) re-evaluated and confirmed the validity of the MIT with PPD, ascribing prior failures to technical problems. We also reconfirmed this point using the same model. MIT correlated well with the skin test, using tuberculin PPD as antigen (Fig. 1, Tables 1, 2) .
The involvement of humoral-type immunity in SLE has been extensively studied and its pathogenetic role well documented, e.g. detection of antinuclear antibodies and/or free DNA in patients' sera (Seligmann, 1957; Deicher et al., 1959; Holman et al., 1959; Stollar et al., 1962; Tan et al., 1966; Pincus et al., 1969; Hughes, 1971; Harbeck et al., 1973) , a lowered level of serum complement (Lange et al., 1960; Lagrue et al., 1966; Asano et al., 1968) , and the demonstration of DNA-anti-DNA antibody complex together with complement in glomeruli (McCluskey et al., 1966; Lange et al., 1966; Koffler et al., 1967) , etc. On the other hand, fewer studies have been done on cell-mediated immunity and its role in the disease process is still controversial.
With regard to the hypersensitivity to DNA, since our report (Ores and Lange, 1964) on positive skin tests to DNA, Patrucco et al. (1967) published their results on a blast-like transformation of lymphocytes cultured in vitro with calf thymus DNA. A similar report was published independently by one of us (Okubo, 1968) . Podleski and Podleski (1973) observed in vitro specific cytotoxic effects of lymphocytes from SLE against DNA-coated human cells. Recently, Abe et al. (1973) reported that the migration inhibition factor was produced by incubating lymphocytes taken from SLE patients with calf thymus DNA. Similar positive results were reported by Galanaud et al. (1971 ), Dormont et al. (1972 ), Moulias et al. (1972 , using a Bendixentype direct MIT. Our study, using the same direct MIT, gave positive results in 65 3 % of SLE patients, using double-stranded calf thymus DNA as antigen (Fig. 2, Table 1 ). In the control subjects the MII was negative except in 2 cases (Cases 28, 40) . In agreement with the observations of Moulias et al. (1972) and Dormont et al. (1972) , no correlation was found between the MIT and other clinical or laboratory data of SLE excepting nephropathy (see below).
However, other workers reported negative results using similar methods, e.g. Reinert et al. (1971) (lymphocyte transformation test), Horwitz (1972) (skin test and lymphocyte culture in vitro), Dormont et al. (1972) In order to understand the discrepancies many factors have to be considered, such as differences in the techniques used, consequently, the different aspects studied (skin test, lymphoblastogenesis, or migration inhibition factor), the effect of steroid or other immunosuppressive therapy, and most importantly the presence of disturbed or deficient cellular immunity in SLE (Bitter et al., 1971; Horwitz, 1972; Federlin and Helmke, 1972; Williams et al., 1973; Messner et al., 1973) . Steroid therapy, in agreement with previous reports, did not seem to affect profoundly the lymphocytic reactivity in vitro. In one patient (Case 14) the migration inhibition became apparent only after initiation of steroid therapy, while in 2 other patients (Cases 8, 17 ) no further inhibition was observed during steroid administration. Our result seemed related more to the disease activity itself than to dosage or duration of steroid therapy.
That disturbed cell-mediated immunity occurs in SLE has long been suggested by frequent falsenegative skin tests with tuberculin antigen. Bitter et al. (1971) and Horwitz (1972) observed a depressed intradermal reaction to prevalent bacterial or fungal antigens in their SLE patients. As for the stimulation study by phytohaemagglutinin, Bitter et al. (1971) could not produce a stimulation response, while Horwitz (1972) found a normal response. Using the MIT, Federlin and Helmke (1972) showed depressed cellular hypersensitivity to DNA in SLE, while Williams et al. (1973) and Messner et al. (1973) reported a decrease in the number of T lymphocytes in the peripheral blood of SLE patients. In one of our cases (Case 2) the MII with PPD as antigen fluctuated from 63 to 132 %, possibly suggesting that deranged cellular immunity may affect the MII titre.
Recently it has been suggested that cell-mediated immunity may play a role in the development of lupus nephropathy (Goldman et al., 1972; Abe et al., 1973) . Goldman et al. (1972) reported that 3 of 6 SLE patients with active nephritis showed a positive response to rabbit native DNA when lymphocytes were cultured in vitro. All 10 SLE patients with the nephrotic syndrome studied by Abe et al. (1973) showed a positive migration inhibition factor sometime during the clinical course. Abe et al. further referred to the possible role of cell-mediated immunity in the perpetuation of renal disease.
Our results were compatible with previous data in that the MIT was positively correlated with the presence of proteinuria and/or granular casts in the urinary sediment. We performed kidney biopsies in 22 of our 26 SLE patients, aiming for prompt diagnosis and treatment of their renal disease. In 16 of these 22 patients the MIT was performed simultaneously (Table 3) 
